Table 3.
Methodological quality assessment of studies included
| Study | Risk of bias | Applicability concerns | |||||
|---|---|---|---|---|---|---|---|
| Patient selection | Index test | Reference standard | Flow and timing | Patient selection | Index test | Reference standard | |
| Virginie Lemiale 2021 | LR | LR | LR | LR | LC | LC | LC |
| Oriol Roca 2016 | LR | LR | LR | LR | LC | UC | LC |
| Oriol Roca 2019 | LR | LR | LR | LR | LC | LC | LC |
| Ken Junyang Goh 2020 | LR | UR | LR | LR | LC | LC | LC |
| Abhimanyu Chandel 2020 | LR | UR | LR | LR | LC | LC | LC |
| Ming Hu 2020 | UR | UR | LR | LR | LC | LC | LC |
| Maeva Rodriguez 2019 | UR | UR | LR | UR | LC | UC | LC |
| Gregory L Calligaro 2020 | LR | UR | LR | LR | LC | LC | LC |
| Jiqian Xu 2020 | LR | UR | LR | LR | LC | LC | LC |
LR low risk; HR high risk; UR unclear risk; LC low concern; HC high concern; UC unclear concern